These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 11438053)

  • 21. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline prognostic factors predict rapid visual field deterioration in glaucoma.
    Lee JM; Caprioli J; Nouri-Mahdavi K; Afifi AA; Morales E; Ramanathan M; Yu F; Coleman AL
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2228-36. PubMed ID: 24458154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual field progression in patients with initially unilateral visual field loss from chronic open-angle glaucoma.
    Chen PP; Park RJ
    Ophthalmology; 2000 Sep; 107(9):1688-92. PubMed ID: 10964831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C.
    Kashiwagi K; Kogure S; Mabuchi F; Chiba T; Yamamoto T; Kuwayama Y; Araie M;
    Acta Ophthalmol; 2016 Nov; 94(7):e561-e570. PubMed ID: 27156361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression of visual field defects and visual loss in trabeculectomized eyes.
    Ehrnrooth P; Puska P; Lehto I; Laatikainen L
    Graefes Arch Clin Exp Ophthalmol; 2005 Aug; 243(8):741-7. PubMed ID: 15700183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prior rates of visual field loss and lifetime risk of blindness in glaucomatous patients undergoing trabeculectomy.
    Foulsham WS; Fu L; Tatham AJ
    Eye (Lond); 2015 Oct; 29(10):1353-9. PubMed ID: 26315699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rates of glaucomatous visual field change before and after transscleral cyclophotocoagulation: a retrospective case series.
    Bleisch D; Furrer S; Funk J
    BMC Ophthalmol; 2015 Dec; 15():179. PubMed ID: 26667206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of the visual field index in clinical glaucoma care.
    Cohen SL; Rosen AI; Tan X; Kingdom FA
    Can J Ophthalmol; 2016 Dec; 51(6):445-451. PubMed ID: 27938956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage.
    Quigley HA; Tielsch JM; Katz J; Sommer A
    Am J Ophthalmol; 1996 Sep; 122(3):355-63. PubMed ID: 8794708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The long-term outcome of glaucoma filtration surgery.
    Parc CE; Johnson DH; Oliver JE; Hattenhauer MG; Hodge DO
    Am J Ophthalmol; 2001 Jul; 132(1):27-35. PubMed ID: 11438050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term relationship between intraocular pressure and visual field loss in primary open-angle glaucoma.
    Inatani M; Iwao K; Inoue T; Awai M; Muto T; Koga T; Ogata-Iwao M; Hara R; Futa R; Tanihara H
    J Glaucoma; 2008; 17(4):275-9. PubMed ID: 18552612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, double-masked, placebo-controlled trial: baseline characteristics.
    Lascaratos G; Garway-Heath DF; Burton R; Bunce C; Xing W; Crabb DP; Russell RA; Shah A;
    Ophthalmology; 2013 Dec; 120(12):2540-2545. PubMed ID: 24126032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trabeculotomy combined with phacoemulsification and implantation of intraocular lens for primary open-angle glaucoma.
    Mizoguchi T; Kuroda S; Terauchi H; Nagata M
    Semin Ophthalmol; 2001 Sep; 16(3):162-7. PubMed ID: 15513436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression of visual field loss in untreated glaucoma patients and suspects in St Lucia, West Indies.
    Wilson MR
    Trans Am Ophthalmol Soc; 2002; 100():365-410. PubMed ID: 12545702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Otago glaucoma surgery outcome study: long-term results of trabeculectomy--1976 to 1995.
    Molteno AC; Bosma NJ; Kittelson JM
    Ophthalmology; 1999 Sep; 106(9):1742-50. PubMed ID: 10485545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rate of progression of total, upper, and lower visual field defects in patients with open-angle glaucoma and high myopia.
    Yoshino T; Fukuchi T; Togano T; Sakaue Y; Seki M; Tanaka T; Ueda J
    Jpn J Ophthalmol; 2016 Mar; 60(2):78-85. PubMed ID: 26822678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continued visual field progression in eyes with prior visual field progression in patients with open-angle glaucoma.
    Chen PP; Cady RS; Mudumbai RC; Ngan R
    J Glaucoma; 2010 Dec; 19(9):598-603. PubMed ID: 20179616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term results of trabeculectomy in patients with open angle and angle-closure glaucoma].
    Pałenga-Pydyn D; Grymin H; Kowalska G; Langner P; Omulecki W
    Klin Oczna; 2004; 106(1-2 Suppl):176-8. PubMed ID: 15510489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twenty-year outcomes in patients with newly diagnosed glaucoma: mortality and visual function.
    King C; Sherwin JC; Ratnarajan G; Salmon JF
    Br J Ophthalmol; 2018 Dec; 102(12):1663-1666. PubMed ID: 29502068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.